Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.2011.826
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
2018English

Management of Hypertension in Patients With Chronic Kidney Disease and End-Stage Renal Disease

Hypertension Journal
2018English

Periodontal Disease in Chronic Kidney Disease and End-Stage Renal Disease Patients: A Review

CardioRenal Medicine
UrologyCardiovascular MedicineCardiology
2013English

Fibroblast Growth Factor 23 Is Upregulated in the Kidney in a Chronic Kidney Disease Rat Model

PLoS ONE
Multidisciplinary
2018English

Chronic Kidney Disease and the Risk of End-Stage Renal Disease Versus Death

Journal of General Internal Medicine
Internal Medicine
2010English

A Practical Approach to the Treatment of Depression in Patients With Chronic Kidney Disease and End-Stage Renal Disease

Kidney International
Nephrology
2012English

Optimal Management of Bone Mineral Disorders in Chronic Kidney Disease and End Stage Renal Disease

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Peritoneal Dialysis in End-Stage Renal Disease Patients With Preexisting Chronic Liver Disease and Ascites

American Journal of Medicine
Medicine
1992English

Visit-To-Visit Variability of Blood Pressure and Death, End-Stage Renal Disease, and Cardiovascular Events in Patients With Chronic Kidney Disease

Journal of Hypertension
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy